3089.6000 -2.10 (-0.07%)
NSE Oct 29, 2025 15:31 PM
Volume: 58,347
 

ICICI Securities Limited
Dr Lal PathLabs’ (Dr Lal) Q1FY25 result was in line with our expectations. Growth was driven by better uptick in Swasthfit (up 26.4% YoY) overall sample volume rose 9.3% YoY.
Dr. Lal Pathlabs Ltd. is trading below its 30 day SMA of 3180.8
More from Dr. Lal Pathlabs Ltd.
Recommended